Bicoll announces the signing of a new partnership with Genfit and the partial financing of a 3.2 million euro joint EuroTrans-Bio project by ERA-Net/ European Commission

Munich, Germany – July 3, 2007 – The Bicoll GmbH, a biopharmaceutical company specializing in
high-tech natural product chemistry to identify novel small molecules for drug discovery and related
innovative fields, today announces the signing of a collaboration agreement with Genfit SA (ALGFT)
(Lille, France), a biopharmaceutical company committed to drug discovery and development in the
field of cardiovascular, inflammatory and metabolic disease.